Newly approved cancer drugs in China — innovation and clinical benefit

待确认 10 由王睿童发布于 2026/3/11 10:40:51

DOI:10.1038/s41571-023-00728-3
作者：Yichen Zhang,?Anita K. Wagner,?Xiaodong Guan
文献类型：期刊论文
补充材料：只需要正文

Nature

Abstract：Around 100 new cancer drugs, defined as new molecular entities, were approved in China between 2005 and 2021. More than half of these new cancer drugs do not constitute innovations in mechan

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

1天前

ming18

9dea73091cf411f1ab3434735aa3bc31.pdf

1天前

Book学术机器人

2026/3/11 10:40:51 未找到该文献，机器人已退出，请等待人工下载

2026/3/11 10:40:51 Book学术AI机器人收到请求，开始寻找文献

2026/3/11 10:40:51 已向机器人发送请求

1天前

王睿童发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Thieme Medical PublishersOne-Pot Carbon-Chain Extension for Nervonic/Carboxylic Acid Synthesis with the Assistance of Microwaves and Lithium Chloride